New Zealand markets closed

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.8800+0.0100 (+0.53%)
At close: 04:00PM EDT
1.9200 +0.04 (+2.13%)
Pre-market: 06:30AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
17,171
193,650
205,530
191,859
-
Other short-term investments
157,338
0
99,696
124,260
-
Total cash
174,509
193,650
305,226
316,119
-
Net receivables
3,432
35,986
790
798
-
Other current assets
4,995
7,466
4,285
7,096
-
Total current assets
182,936
237,102
310,301
324,013
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
30,866
35,394
39,154
40,871
-
Accumulated depreciation
-14,688
-14,373
-13,832
-11,426
-
Net property, plant and equipment
16,178
21,021
25,322
29,445
-
Goodwill
949
949
949
949
-
Intangible assets
729
875
1,021
1,167
-
Other long-term assets
1,000
944
1,818
3,089
-
Total non-current assets
18,856
23,789
29,110
34,650
-
Total assets
201,792
260,891
339,411
358,663
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,458
2,809
2,818
2,996
-
Taxes payable
-
-
-
-
0
Accrued liabilities
17,599
24,450
30,618
19,864
-
Deferred revenues
132,267
121,267
40,816
42,056
-
Total current liabilities
155,913
152,608
77,870
68,111
-
Non-current liabilities
Deferred revenues
80,048
180,059
243,944
276,651
-
Other long-term liabilities
3,893
-
-
-
850
Total non-current liabilities
93,326
194,034
262,000
298,326
-
Total liabilities
249,239
346,642
339,870
366,437
-
Stockholders' equity
Common stock
1
1
1
1
-
Retained earnings
-723,448
-722,879
-623,562
-507,692
-
Accumulated other comprehensive income
95
10
-242
-47
-
Total stockholders' equity
-47,447
-85,751
-459
-7,774
-
Total liabilities and stockholders' equity
201,792
260,891
339,411
358,663
-